JPY 128.0
(-0.78%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 4.58 Billion JPY | 98.3% |
2022 | 2.31 Billion JPY | 53.63% |
2021 | 1.5 Billion JPY | 47.04% |
2020 | 1.02 Billion JPY | 52.34% |
2019 | 672.41 Million JPY | 104.48% |
2018 | 328.84 Million JPY | 43.84% |
2017 | 228.61 Million JPY | -62.88% |
2016 | 615.85 Million JPY | 334.21% |
2015 | 141.83 Million JPY | 42.15% |
2014 | 99.77 Million JPY | -6.89% |
2013 | 107.16 Million JPY | 234.74% |
2012 | 32.01 Million JPY | -97.11% |
2011 | 1.1 Billion JPY | 599.46% |
2010 | 158.32 Million JPY | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 1.48 Billion JPY | -7.4% |
2023 Q3 | 1.14 Billion JPY | 13.74% |
2023 FY | 4.58 Billion JPY | 98.3% |
2023 Q1 | 827.16 Million JPY | 9.47% |
2023 Q2 | 1 Billion JPY | 22.02% |
2023 Q4 | 1.6 Billion JPY | 39.76% |
2022 FY | 2.31 Billion JPY | 53.63% |
2022 Q4 | 755.61 Million JPY | 31.61% |
2022 Q2 | 560.75 Million JPY | 32.38% |
2022 Q1 | 423.58 Million JPY | -16.26% |
2022 Q3 | 574.13 Million JPY | 2.39% |
2021 Q2 | 299.36 Million JPY | -12.16% |
2021 FY | 1.5 Billion JPY | 47.04% |
2021 Q4 | 505.84 Million JPY | 40.44% |
2021 Q3 | 360.2 Million JPY | 20.32% |
2021 Q1 | 340.82 Million JPY | 6.77% |
2020 FY | 1.02 Billion JPY | 52.34% |
2020 Q1 | 209.59 Million JPY | 26.6% |
2020 Q2 | 263.17 Million JPY | 25.56% |
2020 Q3 | 232.39 Million JPY | -11.7% |
2020 Q4 | 319.21 Million JPY | 37.36% |
2019 Q3 | 190.84 Million JPY | 9.46% |
2019 Q4 | 165.55 Million JPY | -13.25% |
2019 FY | 672.41 Million JPY | 104.48% |
2019 Q1 | 141.65 Million JPY | 5.0% |
2019 Q2 | 174.36 Million JPY | 23.09% |
2018 Q3 | 73.91 Million JPY | 9.37% |
2018 FY | 328.84 Million JPY | 43.84% |
2018 Q1 | 52.44 Million JPY | -14.63% |
2018 Q4 | 134.91 Million JPY | 82.53% |
2018 Q2 | 67.57 Million JPY | 28.86% |
2017 Q2 | 38.93 Million JPY | -41.24% |
2017 Q1 | 66.25 Million JPY | -87.87% |
2017 FY | 228.61 Million JPY | -62.88% |
2017 Q4 | 61.42 Million JPY | -0.92% |
2017 Q3 | 61.99 Million JPY | 59.23% |
2016 FY | 615.85 Million JPY | 334.21% |
2016 Q4 | 546.42 Million JPY | 1343.85% |
2016 Q3 | 37.84 Million JPY | 60.95% |
2016 Q2 | 23.51 Million JPY | 191.48% |
2016 Q1 | 8.06 Million JPY | -88.31% |
2015 FY | 141.83 Million JPY | 42.15% |
2015 Q1 | 46.75 Million JPY | -53.14% |
2015 Q3 | 20.06 Million JPY | 235.61% |
2015 Q2 | 5.97 Million JPY | -87.21% |
2015 Q4 | 69.03 Million JPY | 244.01% |
2014 Q3 | - JPY | 0.0% |
2014 FY | 99.77 Million JPY | -6.89% |
2014 Q1 | - JPY | -100.0% |
2014 Q2 | - JPY | 0.0% |
2014 Q4 | 99.77 Million JPY | 0.0% |
2013 Q3 | 7.09 Million JPY | 379.7% |
2013 FY | 107.16 Million JPY | 234.74% |
2013 Q1 | 47.89 Million JPY | 49.68% |
2013 Q2 | 1.47 Million JPY | -96.91% |
2013 Q4 | 50.69 Million JPY | 615.02% |
2012 Q4 | 32 Million JPY | 246053.85% |
2012 Q2 | - JPY | 0.0% |
2012 Q1 | - JPY | -100.0% |
2012 FY | 32.01 Million JPY | -97.11% |
2012 Q3 | 13 Thousand JPY | 0.0% |
2011 Q2 | - JPY | -100.0% |
2011 Q4 | 707.38 Million JPY | 0.0% |
2011 Q1 | 400 Million JPY | 0.0% |
2011 FY | 1.1 Billion JPY | 599.46% |
2011 Q3 | - JPY | 0.0% |
2010 FY | 158.32 Million JPY | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
DVx Inc. | 45.85 Billion JPY | 89.992% |
Seikagaku Corporation | 36.21 Billion JPY | 87.328% |
Eiken Chemical Co., Ltd. | 40.05 Billion JPY | 88.543% |
Create Medic Co., Ltd. | 12.58 Billion JPY | 63.539% |
PHC Holdings Corporation | 353.9 Billion JPY | 98.703% |
Techno Medica Co., Ltd. | 10.28 Billion JPY | 55.378% |
Rion Co., Ltd. | 25.72 Billion JPY | 82.163% |
Nihon Kohden Corporation | 221.98 Billion JPY | 97.933% |
Fukuda Denshi Co., Ltd. | 140.32 Billion JPY | 96.73% |
Japan Lifeline Co., Ltd. | 51.38 Billion JPY | 91.07% |
Japan Medical Dynamic Marketing, INC. | 23.17 Billion JPY | 80.202% |
CYBERDYNE Inc. | 4.35 Billion JPY | -5.393% |